CD8+ T Effector cell response to Keratin 8 was significantly increased in the CAD patient PBMCs compared to Controls (Fig 10A), with the difference found mainly in the TEMRA response (Fig 10B and 10C). This evidence concerns the gene CD8A and coronary artery disorder.